We are live on ! Find out more
OFM

Omega Fund Management Portfolio holdings

AUM $163M
1-Year Est. Return 107.06%
This Fund
S&P 500
This Quarter Est. Return
+2.48%
1 Year Est. Return
+107.06%
3 Year Est. Return
+111.75%
5 Year Est. Return
+84.24%
10 Year Est. Return
+495.59%
AUM
$891M
AUM Growth
+$7.78M
Cap. Flow
+$63.7M
Cap. Flow %
7.14%
Top 10 Hldgs %
87.29%
Holding
26
New
3
Increased
3
Reduced
3
Closed
–

Top Buys

Rank Stock Value
1
IMGO
Imago BioSciences, Inc. Common stock
IMGO
+$64.8M
2
IVVD icon
Invivyd
IVVD
+$23.5M
3
ICVX
Icosavax, Inc. Common Stock
ICVX
+$14.5M
4
ALPN
Alpine Immune Sciences Inc
ALPN
+$6.86M
5
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
+$1.16M

Top Sells

Rank Stock Value
1
MORF
Morphic Holding, Inc. Common Stock
MORF
+$27.3M
2
AVIR icon
Atea Pharmaceuticals
AVIR
+$16.2M
3
REPL icon
Replimune Group
REPL
+$3.64M

Sector Composition

Rank Sector Weight
1 Healthcare 99.45%
2 Financials 0.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KYNB
26
Kyntra Bio
KYNB
$27.4M
$1.15M 0.13%
5,226
– –
1
2

Similar funds

PCR
Potrero Capital Research San Francisco, California $163M AUM 79.07% 1-Year Est. Return
IVGAI
Index Venture Growth Associates IV St. Helier, Jersey $163M AUM 54.88% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
TCGDR
TB Capital Gestao de Recursos Rio De Janeiro $163M AUM 20.86% 1-Year Est. Return
IPWA
International Private Wealth Advisors San Diego, California $163M AUM 16.99% 1-Year Est. Return
GP
Gridiron Partners Wexford, Pennsylvania $164M AUM 3.31% 1-Year Est. Return
PWAM
Papamarkou Wellner Asset Management New York $164M AUM 25.23% 1-Year Est. Return
ACM
Alamar Capital Management Santa Barbara, California $164M AUM 19.77% 1-Year Est. Return

Omega Fund Management's Q3 2021 Portfolio in Review

As of Q3 2021, Omega Fund Management held 26 positions worth $891M, up 0.88% from $884M the previous quarter. Its ten largest holdings account for 87% of the portfolio.

Omega Fund Management deployed $63.7M of net new capital in Q3 2021, opening 3 new positions and adding to 3 existing holdings. Its largest new stake was Imago BioSciences, Inc. Common stock: 3,018,737 shares worth $60.5M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 99% a quarter earlier, followed by Financials.

On the sell side, the largest reduction was Morphic Holding, Inc. Common Stock, an estimated $27.3M trimmed.

  • Omega Fund Management's largest Q3 2021 buy was Imago BioSciences, Inc. Common stock: 3,018,737 shares worth $60.5M.
  • Omega Fund Management added most to Alpine Immune Sciences Inc in Q3 2021, an estimated $6.86M increase.
  • Omega Fund Management's biggest Q3 2021 reduction was Morphic Holding, Inc. Common Stock, cutting an estimated $27.3M.
  • Omega Fund Management's ten largest holdings make up 87% of its $891M portfolio in Q3 2021.
  • Omega Fund Management opened 3 new positions and closed 0 in Q3 2021.
  • Omega Fund Management's portfolio value rose 0.88% quarter-over-quarter to $891M.

Based on Omega Fund Management's 13F filing for Q3 2021, filed 15 Nov 2021.